Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: Hengrui Launches US Subsidiary to Bring Novel Medicines to Global Markets

Week in Review: Zhaoke Signs $130 Million Deal for Vision-Improving Eyedrops

Week in Review: OrbiMed Plans to Raise $1.1 Billion for Fifth Asia Fund

Week in Review: I-Mab Files for Hong Kong SPAC IPO to Acquire Life Science Company

Week in Review: Wuhan Binhui Raises $47 Million for Oncolytic Virus Products

ChinaBio Event
Beijing and Digital
September 13-16, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022